Postdoctoral Fellow in Mechanisms of Cancer Evolution
- Employer
- German Cancer Research Center in the Helmholtz Association (DKFZ)
- Location
- Heidelberg, Baden-Württemberg (DE)
- Salary
- Remuneration according to TV-L incl. company pension scheme and capital-forming benefits
- Closing date
- 12 Sep 2024
- Website
- https://www.dkfz.de/
View more categoriesView less categories
- Discipline
- Biomedicine, Health Science
- Job Type
- Postdoctoral
- Employment - Hours
- Full time
- Duration
- Fixed term
- Qualification
- Professional certification
- Sector
- Academia
Job Details
„Research for a life without cancer“ is our mission at the German Cancer Research Center. We investigate how cancer develops, identify cancer risk factors and look for new cancer prevention strategies. We develop new methods with which tumors can be diagnosed more precisely and cancer patients can be treated more successfully. Every contribution counts – whether in research, administration or infrastructure. This is what makes our daily work so meaningful and exciting.
The Division of Regulatory Genomics and Cancer Evolution (headed by Prof. Dr. Duncan Odom) at the German Cancer Research Center (DKFZ) is seeking a
Postdoctoral Fellow in Mechanisms of Cancer Evolution
Reference number: 2024-0230
LAB PHILOSOPHY. The Odom laboratory uses cutting-edge experimental genomics tools – including spatial transcriptomics, nanopore and other long-read sequencing, and cell multiomics – to explore mutagenesis, cancer initiation, and development. We pursue an integrative and collaborative approach, working closely with allied computational research groups across Heidelberg.
For more information on Odom laboratory research, please see:
www.scholar.google.co.uk/citations?hl=en&user=I4QxyoQAAAAJ
Your Tasks:
PROJECT ON OFFER. We are specifically seeking a candidate to lead a team of advanced technicians to undertake a large-scale, prospective analysis of how sex shapes mutagenesis and cancer inception.This project builds on our pioneering development of chemical carcinogens as a powerful strategy to analyze cancer inception in mice (Connor et al J Hepatology 2018). Early work using this system revealed a novel mechanism of cancer formation known as lesion segregation (Aitken et al Nature 2020) and dissected the interplay of repair and damage at single-strand resolution (Anderson et al Nature 2024). This project will create and analyze cancer genomes formed in female mice, as well as exploit the four core genotypes model to decouple the influence of hormones and sex chromosomes (Panten et al Nature Comms 2024). By using cutting-edge spatial mapping of single-cell transcriptomes, we will analyze how the sex-specific microenvironment shapes tumorigenesis.
DUTIES. This project will require strong and collaborative leadership to organize Odom laboratory technicians and computational collaborators (and potentially clinical partners) into an effective research team. The post holder will be responsible for project management, method development and optimization, collection and analysis of novel and large genomic datasets. The training we provide in this multi-disciplinary team environment is uniquely well-suited to nurturing scientific independence, leadership, and maturity.
Your Profile:
DESIRED CANDIDATE. We are seeking an experimentally-focused postdoctoral research fellow with extensive molecular biology and genomics expertise to join our efforts, who is collaborative, ambitious, meticulous, scientifically adventurous, and curiosity-driven. Prior research experience in single-cell methods, transcriptional regulation, cancer genomics, epigenetics, evolutionary biology, bioinformatics, and/or comparative genomics would be advantageous; we also encourage applications from accomplished graduate students seeking to switch research fields.
We Offer:
- Excellent framework conditions: state-of-the-art equipment and opportunities for international networking at the highest level
- Remuneration according to TV-L incl. company pension scheme and capital-forming benefits
- 30 days of vacation per year
- Flexible working hours
- Possibility of part-time work
- Family-friendly working environment
- Sustainable travel to work: subsidized Germany job ticket
- Our Corporate Health Management Program offers a holistic approach to your well-being
- Develop your full potential: access to the DKFZ International Postdoc Program and DKFZ Career Service with targeted offers for your personal development to further develop your talents
Contact:
Prof. Dr. Duncan Odom
Telefon: +49 6221 42-3446
The position is initially limited to 2 years with the possibility of prolongation.
Are you interested?
Then become part of the DKFZ and join us in contributing to a life without cancer!
We are convinced that an innovative research and working environment thrives on the diversity of its employees. Therefore, we welcome applications from talented people, regardless of gender, cultural background, nationality, ethnicity, sexual identity, physical ability, religion and age. People with severe disabilities are given preference if they have the same aptitude.
Notice: We are subject to the regulations of the Infection Protection Act (IfSG). Therefore, all our employees must provide proof of immunity against measles.
Company
About the German Cancer Research Center (DKFZ)
The German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) is Germany’s largest biomedical research institute and a member of the Helmholtz Association of German Research Centers. Over 3,200 staff members from 88 nations are dedicated to performing and driving cutting edge research for a life without cancer. Organized in more than 100 divisions and research groups, the focus of our 1,400 scientists is to unravel the causes and mechanisms of cancer development and progression, and to develop novel strategies for the diagnosis, early detection, prevention and treatment of cancer though innovative translational research.
Scientists at the DKFZ have received the most prestigious academic awards, including Prof. Harald zur Hausen, awarded the Nobel Prize in Physiology or Medicine in 2008 for his pioneering work on Human Papilloma Viruses (HPV),and Prof. Stefan Hell, who received the Nobel Prize in Chemistry for his research on super-resolution imaging.
The DKFZ core site is located in Heidelberg, the “City of Science”, which is considered one of the most beautiful cities in Germany with a highly international community: An estimated 56,000 of Heidelberg’s 160,000 inhabitants have an international background – many of whom are scientists or students.
Research Topics and Scientific Collaborations
The DKFZ is an international leader in a number of research areas including stem cell research, bioinformatics and systems biology, cancer genomics, neurooncology, pediatric oncology, cancer prevention, tumor immunology, virology, radiooncology and medical image analysis. The interdisciplinary and collaborative research environment at the DKFZ also results in excellent opportunities for computational and data scientists with interest in biomedical applications.
Research at the DKFZ is organized into six research programs:
- Cell and Tumor Biology
- Functional and Structural Genomics
- Cancer Risk Factors and Prevention
- Immunology and Cancer
- Imaging and Radiooncology
- Infection, Inflammation and Cancer
On the mission for a life without cancer, the DKFZ collaborates with renowned clinical and research institutions at the local, national and international level. A key goal is to continuously strengthen translational research activities with the aim of sustainably advancing state-of-the-art clinical cancer research in Germany and thereby improving the treatment outcomes and quality of life of cancer patients. Together with University Hospital partners across Germany, the DKFZ established the National Centers for Tumor Diseases (NCT) as leading Comprehensive Cancer Centers in Germany, as well as the Hopp Childrens’ Tumor Center (KiTZ) in Heidelberg with a specific focus on pediatric oncology. Within the German Cancer Consortium for Translational Cancer Research (DKTK), research institutions and university hospitals at eight partner locations collaborate with the DKFZ, the core center of the DKTK, to speed up the transfer of successful cancer research into clinical practice. Furthermore, the HI-TRON in Mainz is a cooperative effort to make full use of the potential of individualized immunotherapy.
Training Programs and Career Development
Talent management and career development are central parts of DKFZ’s mission to maintain scientific excellence. The DKFZ places strong emphasis on the international recruitment and comprehensive training of excellent scientists, specifically welcoming diverse and international backgrounds.
Dedicated programs train young scientists and clinicians and prepare them for their next career step:
- DKFZ Major in Cancer Biology within the International Master Program
'Molecular Biosciences' - DKFZ International PhD Program
- DKFZ International Postdoc Program
- DKFZ Clinician Scientist Program
- DKFZ Junior Research Groups
The DKFZ has developed programs to support the reconciliation of family and careers at all levels and international employees are supported by the International Staff Services in the planning, preparation and realization of their stay in Heidelberg.
Innovation Management
The DKFZ builds on strong Innovation Management to foster the development of innovative preventive, diagnostic and therapeutic products for maximum societal benefit. It facilitates technology transfer through licensing and support of spin-off companies. Recent examples include iOmx Therapeutics, Apogenix and mtm laboratories. The DKFZ also has strong collaborations with industry partners, such as Bayer Healthcare, Bosch, SAP and Siemens.
- Telephone
- +49 (0) 6221 420
- Location
-
Im Neuenheimer Feld 280
Heidelberg
Baden-Württemberg
D-69120
DE
Get job alerts
Create a job alert and receive personalised job recommendations straight to your inbox.
Create alert